Cargando…

Peroxisome proliferator–activated receptor (PPAR)α expression in T cells mediates gender differences in development of T cell–mediated autoimmunity

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Dunn, Shannon E., Ousman, Shalina S., Sobel, Raymond A., Zuniga, Luis, Baranzini, Sergio E., Youssef, Sawsan, Crowell, Andrea, Loh, John, Oksenberg, Jorge, Steinman, Lawrence
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2007
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2137918/ http://dx.doi.org/10.1084/jem.20061839020807c

Ejemplares similares

Peroxisome proliferator–activated receptor (PPAR)α expression in T cells mediates gender differences in development of T cell–mediated autoimmunity
por: Dunn, Shannon E., et al.
Publicado: (2007)

Correction: Peroxisome proliferator–activated receptor (PPAR)α expression in T cells mediates gender differences in development of T cell–mediated autoimmunity
por: Dunn, Shannon E., et al.
Publicado: (2018)

Peroxisome proliferator–activated receptor δ limits the expansion of pathogenic Th cells during central nervous system autoimmunity
por: Dunn, Shannon E., et al.
Publicado: (2010)

Neither T-helper type 2 nor Foxp3(+) regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity
por: Weber, Martin S, et al.
Publicado: (2014)

PPARα-mediated peroxisome induction compensates PPARγ-deficiency in bronchiolar club cells
por: Karnati, Srikanth, et al.
Publicado: (2018)

Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin
por: Dunn, Shannon E., et al.
Publicado: (2006)

Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunity
por: Schulze-Topphoff, Ulf, et al.
Publicado: (2013)

Immune cell-specific transcriptional profiling highlights distinct molecular pathways controlled by Tob1 upon experimental autoimmune encephalomyelitis
por: Didonna, Alessandro, et al.
Publicado: (2016)

Mechanisms Mediating the Regulation of Peroxisomal Fatty Acid Beta-Oxidation by PPARα
por: Tahri-Joutey, Mounia, et al.
Publicado: (2021)

Impaired T cell-mediated hepatitis in peroxisome proliferator activated receptor alpha (PPARα)-deficient mice
por: Hines, Ian N., et al.
Publicado: (2018)

Time-Dependent Vascular Effects of Endocannabinoids Mediated by Peroxisome Proliferator-Activated Receptor Gamma (PPARγ)
por: O'Sullivan, Saoirse E., et al.
Publicado: (2009)

Expression of the Peroxisome Proliferator-Activated Receptors (PPARs) in the Hepatic Stellate Cells
por: Sato, Takeya, et al.
Publicado: (2004)

Mechanisms Involved in the Enhanced Susceptibility of Senescent Rats to the Hepatocarcinogenic Effect of Peroxisome Proliferators: Role of Peroxisome Proliferator-Activated Receptor alpha (PPAR), Cell Proliferation and Oxidative Stress
por: Youssef, Jihan A., et al.
Publicado: (2001)

The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function
por: Gray, Elizabeth, et al.
Publicado: (2012)

PPAR-γ Impairment Alters Peroxisome Functionality in Primary Astrocyte Cell Cultures
por: Di Cesare Mannelli, Lorenzo, et al.
Publicado: (2014)

Immune surveillance in the central nervous system
por: Ousman, Shalina S, et al.
Publicado: (2012)

Cystatin C Plays a Sex-Dependent Detrimental Role in Experimental Autoimmune Encephalomyelitis
por: Hoghooghi, Vahid, et al.
Publicado: (2020)

CAR-T Cell–Mediated B-Cell Depletion in Central Nervous System Autoimmunity
por: Gupta, Sasha, et al.
Publicado: (2023)

Astrocytes and Aging
por: Palmer, Alexandra L., et al.
Publicado: (2018)

The immune response and aging in chronic inflammatory demyelinating polyradiculoneuropathy
por: Hagen, Kathleen M., et al.
Publicado: (2021)

The Neuroimmunology of Guillain-Barré Syndrome and the Potential Role of an Aging Immune System
por: Hagen, Kathleen M., et al.
Publicado: (2021)

Peroxisomes protect lymphoma cells from HDAC inhibitor-mediated apoptosis
por: Dahabieh, Michael S, et al.
Publicado: (2017)

PPAR-δ senses and orchestrates clearance of apoptotic cells to promote tolerance
por: Mukundan, Lata, et al.
Publicado: (2009)

CEACAM1 mediates B cell aggregation in central nervous system autoimmunity
por: Rovituso, Damiano M., et al.
Publicado: (2016)

Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders
por: Cho, Min-Chul, et al.
Publicado: (2008)

Downregulation of peroxisome proliferator-activated receptors (PPARs) in nasal polyposis
por: Cardell, Lars-Olaf, et al.
Publicado: (2005)

The Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Pan-Cancer
por: Huang, Runzhi, et al.
Publicado: (2020)

Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Trophoblast Functions
por: Peng, Lin, et al.
Publicado: (2021)

The function of peroxisome proliferator-activated receptors PPAR-γ and PPAR-δ in Mycobacterium leprae-induced foam cell formation in host macrophages
por: Luo, Yuqian, et al.
Publicado: (2020)

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
por: Syversen, Unni, et al.
Publicado: (2009)

T-cell-mediated control of autoimmunity
por: Mason, Don
Publicado: (2001)

The molecular signature of therapeutic mesenchymal stem cells exposes the architecture of the hematopoietic stem cell niche synapse
por: Pedemonte, Enrico, et al.
Publicado: (2007)

Peroxisome Proliferator-Activated Receptor (PPAR): Balance for Survival in Parasitic Infections
por: Chan, Marion M., et al.
Publicado: (2010)

Metabolic Dysfunction and Peroxisome Proliferator-Activated Receptors (PPAR) in Multiple Sclerosis
por: Ferret-Sena, Véronique, et al.
Publicado: (2018)

Underexpression of peroxisome proliferator-activated receptor (PPAR)γ in PAX8/PPARγ-negative thyroid tumours
por: Marques, A R, et al.
Publicado: (2004)

Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists
por: Sato, H, et al.
Publicado: (2000)

Impaired skin wound healing in peroxisome proliferator–activated receptor (PPAR)α and PPARβ mutant mice
por: Michalik, Liliane, et al.
Publicado: (2001)

Peroxisome Proliferator-Activated Receptor-δ Deficiency in Microglia Results in Exacerbated Axonal Injury and Tissue Loss in Experimental Autoimmune Encephalomyelitis
por: Doroshenko, Ellinore R., et al.
Publicado: (2021)

PPARγ and the Innate Immune System Mediate the Resolution of Inflammation
por: Croasdell, Amanda, et al.
Publicado: (2015)

Regulation of Immune Responses and Autoimmune Encephalomyelitis by PPARs
por: Yang, Yuhong, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_abujegkh200p7p1aoggbnjjni2